focus -WSS

focus

author：Wikipedia 2025-09-30 11:06:39 - browse：23

Balance innovation — Medicare laid out in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be. Adobe

WASHINGTON — Medicare laid out Wednesday in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be.

Democrats outlined some parts of the process in the Inflation Reduction Act that passed Congress last August, but the details of how drugs will be selected and what factors will be considered have been vague until now. Though the actual negotiated prices won’t take effect for years, Medicare officials must announce the first 10 drugs they’ll negotiate over by Sept. 1.

The guidance clarifies that the agency will choose the 50 pharmacy drugs that cost Medicare the most money, based on gross expenditures. If drugs have the same cost to the program, then the one that has been approved longer will be ranked higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Biotech reporter’s notebook: A sunnier mood at JPM 2024

hotspot

Wikipedia

WSS

Generative AI mines health records to identify patients’ social needs

Harvard scientists, with Google, unveil the most detailed brain map ever

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Young boy dies in trial for Pfizer Duchenne gene therapy

First Opinion on colorectal cancer screening: letter and response

Republican states more likely to report Covid vaccine side effects

knowledge

focus

focus

What does generative AI mean for health care? We asked experts

First Opinion on colorectal cancer screening: letter and response

In age of alternative facts, a scholarly course on calling out crap

Trial using CRISPR to edit HIV out of cells disappoints

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

BioMarin wins approval for gene therapy to treat hemophilia A

Researchers test human milk's ability to repair gut microbiome

In age of alternative facts, a scholarly course on calling out crap

Mass General Brigham physicians react to latest merger step

explore

Health and fitness trackers are measuring the wrong things

Three issues to watch in global health in 2024

Oral obesity drug from Viking Therapeutics hits key early target

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

JPM 2024: Verve Therapeutics looks to mainstream genome editing

focus

hotspot

Wikipedia

Wikipedia